Biotech CLASS ACTION UPDATE for SEDG, EIGR and UIS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 19, 2022
Biotech Mustang Bio Provides CAR T Cell Therapy Portfolio Updates and 2023 Anticipated Milestones December 19, 2022
Biotech Cocrystal Pharma Reports Highly Favorable Safety and Tolerability Results from a Phase 1 Study with its Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A December 19, 2022
Biotech Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market December 19, 2022
Biotech ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 17, 2022
Biotech EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm December 16, 2022
Biotech EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm December 16, 2022
Biotech ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 16, 2022
Search
